US Patent Issued to OCHSNER CLINIC FOUNDATION on Jan. 20 for "Renin-angiotensin-aldosterone system (RAAS) inhibitors in the treatment of pancreatic ductal carcinoma" (Louisiana Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,785, issued on Jan. 20, was assigned to OCHSNER CLINIC FOUNDATION (New Orleans).

"Renin-angiotensin-aldosterone system (RAAS) inhibitors in the treatment of pancreatic ductal carcinoma" was invented by Richard N. Re (New Orleans), Xin Zhang (New Orleans) and Li Li (New Orleans).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments provide for methods of treatment for subjects suffering from a condition/disorder or disease for which the renin-angiotensin-aldosterone system (RAAS) plays at least some role. In one example, a method comprises administering to the subject an effective amount of one or more of an angiotensin receptor AT2R antagonist f...